mutLBSgeneDB |
Gene summary for NQO1 |
Gene summary |
Basic gene Info. | Gene symbol | NQO1 |
Gene name | NAD(P)H dehydrogenase, quinone 1 | |
Synonyms | DHQU|DIA4|DTD|NMOR1|NMORI|QR1 | |
Cytomap | UCSC genome browser: 16q22.1 | |
Type of gene | protein-coding | |
RefGenes | NM_000903.2, NM_001025433.1,NM_001025434.1,NM_001286137.1, | |
Description | DT-diaphoraseNAD(P)H dehydrogenase [quinone] 1NAD(P)H:Quinone acceptor oxidoreductase type 1NAD(P)H:menadione oxidoreductase 1NAD(P)H:quinone oxidoreductase 1NAD(P)H:quinone oxireductaseazoreductasediaphorase (NADH/NADPH) (cytochrome b-5 reductase) | |
Modification date | 20141222 | |
dbXrefs | MIM : 125860 | |
HGNC : HGNC | ||
Ensembl : ENSG00000181019 | ||
HPRD : 00518 | ||
Vega : OTTHUMG00000137575 | ||
Protein | UniProt: P15559 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_NQO1 | |
BioGPS: 1728 | ||
Pathway | NCI Pathway Interaction Database: NQO1 | |
KEGG: NQO1 | ||
REACTOME: NQO1 | ||
Pathway Commons: NQO1 | ||
Context | iHOP: NQO1 | |
ligand binding site mutation search in PubMed: NQO1 | ||
UCL Cancer Institute: NQO1 | ||
Assigned class in mutLBSgeneDB | C: This gene just belongs to mutLBSgenes. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO Term | PubMed ID |
Top |
Ligand binding site mutations for NQO1 |
Lollipop-style diagram of mutations at LBS in amino-acid sequence. We represented ligand binding site mutations only. (You can see big image via clicking.) : non-synonymous mutation on LBS, Circle size denotes number of samples. |
Cancer type specific mutLBS sorted by frequency |
LBS | AAchange of nsSNV | Cancer type | # samples | H162 | G163W | LUAD | 1 | A21 | K23N | SKCM | 1 | Y156 | Y156H | STAD | 1 | F179,G175 | L177V | STAD | 1 | M155 | M155I | UCEC | 1 | R201 | R201Q | UCEC | 1 | M132 | A131V | UCEC | 1 |
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
Top |
Protein structure related information for NQO1 |
Relative protein structure stability change (ΔΔE) using Mupro 1.1 Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
: nsSNV at non-LBS: nsSNV at LBS |
nsSNVs sorted by the relative stability change of protein structure by each mutation Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
LBS | AAchange of nsSNV | Relative stability change | R201 | R201Q | -1.5087075 | G175 | L177V | -1.0197914 | F179 | L177V | -1.0197914 | M132 | A131V | -0.97471264 | Y156 | Y156H | -0.69281858 | H162 | G163W | -0.36497249 | M155 | M155I | -0.14559768 | A21 | K23N | -0.013208251 |
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
Structure image for NQO1 from PDB |
Top |
Differential gene expression and gene-gene network for NQO1 |
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types |
Differential co-expressed gene network based on protein-protein interaction data (CePIN) |
Top |
Top |
Phenotype information for NQO1 |
Gene level disease information (DisGeNet) |
Disease ID | Disease name | # PubMed | Association type |
umls:C1961102 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 22 | AlteredExpression, Biomarker, GeneticVariation |
umls:C0007131 | Carcinoma, Non-Small-Cell Lung | 12 | Biomarker, GeneticVariation |
umls:C0004096 | Asthma | 8 | Biomarker, GeneticVariation |
umls:C1458155 | Breast Neoplasms | 8 | Biomarker, GeneticVariation |
umls:C0030567 | Parkinson Disease | 7 | Biomarker, GeneticVariation |
umls:C0027651 | Neoplasms | 7 | Biomarker, GeneticVariation |
umls:C0009404 | Colorectal Neoplasms | 6 | Biomarker, GeneticVariation |
umls:C0005695 | Urinary Bladder Neoplasms | 6 | Biomarker, GeneticVariation |
umls:C0028797 | Occupational Diseases | 6 | Biomarker, GeneticVariation |
umls:C0023470 | Leukemia, Myeloid | 5 | Biomarker, GeneticVariation |
umls:C0026764 | Multiple Myeloma | 5 | Biomarker, GeneticVariation |
umls:C0033578 | Prostatic Neoplasms | 3 | Biomarker, GeneticVariation |
umls:C0023895 | Liver Diseases | 2 | Biomarker |
umls:C0027659 | Neoplasms, Experimental | 2 | Biomarker, Therapeutic |
umls:C0008370 | Cholestasis | 1 | Biomarker |
umls:C0011853 | Diabetes Mellitus, Experimental | 1 | Therapeutic |
umls:C0019061 | Hemolytic-Uremic Syndrome | 1 | Biomarker |
umls:C0020456 | Hyperglycemia | 1 | Therapeutic |
umls:C0022658 | Kidney Diseases | 1 | Therapeutic |
umls:C0235032 | Neurotoxicity Syndromes | 1 | Therapeutic |
umls:C0028754 | Obesity | 1 | Biomarker |
umls:C0030354 | Papilloma | 1 | Biomarker |
umls:C1846707 | Spinocerebellar Ataxia 17 | 1 | Biomarker |
Mutation level pathogenic information (ClinVar annotation) |
Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
Top |
Pharmacological information for NQO1 |
Gene expression profile of anticancer drug treated cell-lines (CCLE) Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient. |
Gene-centered drug-gene interaction network |
Drug information targeting mutLBSgene (Approved drugs only) |
Drug status | DrugBank ID | Name | Type | Drug structure |
Approved|nutraceutical | DB00170 | Menadione | Small molecule | |
Approved | DB00266 | Dicoumarol | Small molecule | |
Experimental | DB01927 | Duroquinone | Small molecule | |
Experimental | DB02395 | 3-Hydroxymethyl-5-Aziridinyl-1methyl-2-[1h-Indole-4,7-Dione]-Propanol | Small molecule | |
Experimental | DB02400 | 5-Methoxy-1,2-Dimethyl-3-(4-Nitrophenoxymethyl)Indole-4,7-Dione | Small molecule | |
Experimental | DB02633 | Cibacron Blue | Small molecule | |
Approved | DB03147 | Flavin adenine dinucleotide | Small molecule | |
Experimental | DB03626 | 5-Methoxy-1,2-Dimethyl-3-(Phenoxymethyl)Indole-4,7-Dione | Small molecule | |
Experimental | DB04090 | 2,5-Diaziridin-1-Yl-3-(Hydroxymethyl)-6-Methylcyclohexa-2,5-Diene-1,4-Dione | Small molecule | |
Experimental | DB04392 | Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone] | Small molecule | |
Experimental | DB07385 | 3-(HYDROXYMETHYL)-1-METHYL-5-(2-METHYLAZIRIDIN-1-YL)-2-PHENYL-1H-INDOLE-4,7-DIONE | Small molecule |
Gene-centered ligand-gene interaction network |
Ligands binding to mutated ligand binding site of NQO1 go to BioLip |
Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS | FAD | FAD | 4cet | A | A21 Y156 R201 | FAD | FAD | 4cf6 | A | A21 Y156 R201 | FAD | FAD | 4cf6 | B | A21 Y156 R201 | CBD | CIBACRON BLUE | 4cf6 | A | F179 | CBD | CIBACRON BLUE | 4cf6 | B | F179 | CBD | CIBACRON BLUE | 4cf6 | A | M155 | CBD | CIBACRON BLUE | 4cf6 | B | M155 H162 | DTC | DICOUMAROL | 4cet | A | M155 Y156 H162 |
Top |
Conservation information for LBS of NQO1 |
Multiple alignments for P15559 in multiple species |
LBS | AA sequence | # species | Species | A21 | TSFNYAMKEAA | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | E118 | LKGWFERVLVA | 2 | Mus musculus, Rattus norvegicus | E118 | LKGWFERVFIG | 1 | Homo sapiens | F107 | FPLQWFGVPAI | 2 | Homo sapiens, Mus musculus | F107 | FPLYWFGVPAI | 1 | Rattus norvegicus | F179 | SGILRFCGFQV | 2 | Mus musculus, Rattus norvegicus | F179 | SGILHFCGFQV | 1 | Homo sapiens | F18 | SERTSFNYAMK | 1 | Homo sapiens | F18 | SEKTSFNYAMK | 1 | Mus musculus | F18 | AERTSFNYAMK | 1 | Rattus norvegicus | F233 | LFDLNFQAGFL | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | F237 | NFQAGFLMKKE | 2 | Homo sapiens, Mus musculus | F237 | NFQAGFLLKKE | 1 | Rattus norvegicus | G123 | ERVLVAGFAYT | 2 | Mus musculus, Rattus norvegicus | G123 | ERVFIGEFAYT | 1 | Homo sapiens | G150 | LSITTGGSGSM | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | G151 | SITTGGSGSMY | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | G175 | WPIQSGILRFC | 2 | Mus musculus, Rattus norvegicus | G175 | WPIQSGILHFC | 1 | Homo sapiens | G194 | LVYSIGHTPPD | 2 | Mus musculus, Rattus norvegicus | G194 | LTYSIGHTPAD | 1 | Homo sapiens | G236 | LNFQAGFLMKK | 2 | Homo sapiens, Mus musculus | G236 | LNFQAGFLLKK | 1 | Rattus norvegicus | H12 | LIVLAHSERTS | 1 | Homo sapiens | H12 | LIVLAHSEKTS | 1 | Mus musculus | H12 | LIVLAHAERTS | 1 | Rattus norvegicus | H162 | SLQGVHGDMNV | 2 | Mus musculus, Rattus norvegicus | H162 | SLQGIHGDMNV | 1 | Homo sapiens | H195 | VYSIGHTPPDA | 2 | Mus musculus, Rattus norvegicus | H195 | TYSIGHTPADA | 1 | Homo sapiens | I161 | YSLQGVHGDMN | 2 | Mus musculus, Rattus norvegicus | I161 | YSLQGIHGDMN | 1 | Homo sapiens | I193 | QLVYSIGHTPP | 2 | Mus musculus, Rattus norvegicus | I193 | QLTYSIGHTPA | 1 | Homo sapiens | I51 | NFNPIISRKDI | 1 | Homo sapiens | I51 | NFNPIISRNDI | 1 | Mus musculus | I51 | NFNPLISRNDI | 1 | Rattus norvegicus | L104 | IFQFPLQWFGV | 2 | Homo sapiens, Mus musculus | L104 | IFQFPLYWFGV | 1 | Rattus norvegicus | L205 | ARIQILEGWKK | 1 | Homo sapiens | L205 | ARMQILEGWKK | 1 | Mus musculus | L205 | ARVQVLEGWKK | 1 | Rattus norvegicus | M132 | YTYAAMYDKGP | 1 | Homo sapiens | M132 | YTYAAMYDNGP | 1 | Mus musculus | M132 | YTYATMYDKGP | 1 | Rattus norvegicus | M155 | GGSGSMYSLQG | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | N19 | ERTSFNYAMKE | 2 | Homo sapiens, Rattus norvegicus | N19 | EKTSFNYAMKE | 1 | Mus musculus | P103 | VIFQFPLQWFG | 2 | Homo sapiens, Mus musculus | P103 | VIFQFPLYWFG | 1 | Rattus norvegicus | P69 | ANFQYPAESVL | 1 | Homo sapiens | P69 | KNFQYPSESSL | 1 | Mus musculus | P69 | ENFQYPVESSL | 1 | Rattus norvegicus | Q105 | FQFPLQWFGVP | 2 | Homo sapiens, Mus musculus | Q105 | FQFPLYWFGVP | 1 | Rattus norvegicus | Q67 | DPANFQYPAES | 1 | Homo sapiens | Q67 | DSKNFQYPSES | 1 | Mus musculus | Q67 | DSENFQYPVES | 1 | Rattus norvegicus | R201 | TPADARIQILE | 1 | Homo sapiens | R201 | TPPDARMQILE | 1 | Mus musculus | R201 | TPPDARVQVLE | 1 | Rattus norvegicus | S152 | ITTGGSGSMYS | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | S154 | TGGSGSMYSLQ | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | S17 | HSERTSFNYAM | 1 | Homo sapiens | S17 | HSEKTSFNYAM | 1 | Mus musculus | S17 | HAERTSFNYAM | 1 | Rattus norvegicus | S192 | PQLVYSIGHTP | 2 | Mus musculus, Rattus norvegicus | S192 | PQLTYSIGHTP | 1 | Homo sapiens | T148 | TLLSITTGGSG | 2 | Mus musculus, Rattus norvegicus | T148 | AVLSITTGGSG | 1 | Homo sapiens | T149 | LLSITTGGSGS | 2 | Mus musculus, Rattus norvegicus | T149 | VLSITTGGSGS | 1 | Homo sapiens | T16 | AHSERTSFNYA | 1 | Homo sapiens | T16 | AHSEKTSFNYA | 1 | Mus musculus | T16 | AHAERTSFNYA | 1 | Rattus norvegicus | W106 | QFPLQWFGVPA | 2 | Homo sapiens, Mus musculus | W106 | QFPLYWFGVPA | 1 | Rattus norvegicus | Y127 | IGEFAYTYAAM | 1 | Homo sapiens | Y127 | VAGFAYTYAAM | 1 | Mus musculus | Y127 | VAGFAYTYATM | 1 | Rattus norvegicus | Y129 | EFAYTYAAMYD | 1 | Homo sapiens | Y129 | GFAYTYAAMYD | 1 | Mus musculus | Y129 | GFAYTYATMYD | 1 | Rattus norvegicus | Y156 | GSGSMYSLQGV | 2 | Mus musculus, Rattus norvegicus | Y156 | GSGSMYSLQGI | 1 | Homo sapiens | Y68 | PANFQYPAESV | 1 | Homo sapiens | Y68 | SKNFQYPSESS | 1 | Mus musculus | Y68 | SENFQYPVESS | 1 | Rattus norvegicus |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |